Evidence map›Paper›PMID 20615496›Full record

SynthesisBiological psychiatry2010

Antidepressant response and the serotonin transporter gene-linked polymorphic region.

Matthew J Taylor, Srijan Sen, Zubin Bhagwagar

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Biological psychiatry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Systematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatment.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2013
    Pooled it
  3. Trial
  4. Trial
  5. Biomarkers in Child and Adolescent Depression.Child psychiatry and human development · 2023
    Review
  6. Precision Medicine in Antidepressants Treatment.Handbook of experimental pharmacology · 2023
    Review
  7. Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression.Advances in experimental medicine and biology · 2021
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Antidepressant Effect ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Matthew J TaylorDepartment of Psychiatry, University of Oxford, United Kingdom. matthew.taylor@psych.ox.ac.uk
Srijan Sen
Zubin Bhagwagar
Bristol-Myers Squibb (United States) · USScience Oxford · GBYale University · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Utilizing Medical Internship to Identify Genetic Variation Associated with DepresK23MH095109 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SEN, SRIJAN · 2011 to 2014
$729k
A study of GABA and 5-HT interactions to test a molecular model of vulnerabilityK23MH077914 · NIMH · YALE UNIVERSITY · PI BHAGWAGAR, ZUBIN · 2007 to 2009
$543k
NCRR NIH HHS UL1 RR024139NIMH NIH HHS K23 MH077914NIMH NIH HHS K23-MH077914NIMH NIH HHS K23 MH095109
6 · The paper itself

Abstract

backgroundThe serotonin transporter gene-linked polymorphic region (5-HTTLPR) has been proposed as a predictor of antidepressant response. Insertion or deletion of a 44-base pair-long region gives rise to short "S" and long "L" forms of the promoter region, the "S" form being associated with reduced serotonin transporter expression.

methodsA systematic review and meta-analysis was performed to clarify the effect of 5-HTTLPR on antidepressant response and remission rates. Data were obtained from 28 studies with 5408 participants. Three genotype comparisons were tested-SS versus (SL or LL), (SS or SL) versus LL, and SS versus LL.

resultsThere was no statistically significant effect on antidepressant response. Compared with L carriers, there was an apparent effect of the SS genotype on remission rate (relative risk: .88; 95% confidence interval: .79-.98; p = .02). However, after trim and fill correction for missing data, the effect disappeared (relative risk: .92; 95% confidence interval: .81-1.05; p = .23), indicating that the initial significant effect was likely the result of publication bias. No significant effect on remission rate was seen for SS versus LL and SS/SL versus LL. Substantial unexplained heterogeneity of effect sizes was observed between studies, pointing to additional interacting factors contributing to an association in some cases.

conclusionsThe 5-HTTLPR biallelic short/long polymorphism by itself does not seem to usefully predict antidepressant response.

Indexed as

Polymorphism, GeneticAllelesAntidepressive AgentsDepressive DisorderGenotypeHumansPromoter Regions, GeneticRemission InductionSerotonin Plasma Membrane Transport ProteinsAntidepressive AgentsSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, human

Identifiers

PMID20615496
PMCPMC2929304
OpenAlexW2049527568

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.